These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 25726942

  • 1. Cost implications of intraprocedural thrombotic events during PCI.
    Plent S, Fan W, Kirtane A, Brener SJ, Genereux P, Mehran R, Pinto DS, McEntegart M, Cohen DJ, Stone GW.
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):30-9. PubMed ID: 25726942
    [Abstract] [Full Text] [Related]

  • 2. Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    McEntegart MB, Kirtane AJ, Cristea E, Brener S, Mehran R, Fahy M, Moses JW, Stone GW.
    J Am Coll Cardiol; 2012 May 15; 59(20):1745-51. PubMed ID: 22575311
    [Abstract] [Full Text] [Related]

  • 3. Intraprocedural thrombotic events: What's the real cost?
    Lipinski MJ, Satler LF.
    Catheter Cardiovasc Interv; 2015 Jul 15; 86(1):40-1. PubMed ID: 26097054
    [Abstract] [Full Text] [Related]

  • 4. Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials.
    Wessler JD, Généreux P, Mehran R, Ayele GM, Brener SJ, McEntegart M, Ben-Yehuda O, Stone GW, Kirtane AJ.
    JACC Cardiovasc Interv; 2016 Feb 22; 9(4):331-337. PubMed ID: 26803422
    [Abstract] [Full Text] [Related]

  • 5. Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
    Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS, CHAMPION PHOENIX ECONOMICS Investigators.
    Catheter Cardiovasc Interv; 2018 Nov 01; 92(5):E348-E355. PubMed ID: 29726596
    [Abstract] [Full Text] [Related]

  • 6. Impact of intraprocedural thrombotic events on short- and long-term outcomes following percutaneous coronary intervention. Evidence from a meta-analysis.
    Nairooz R, Feldman DN, Rochlani Y, Aronow WS, Sardar P, Mukherjee D, Naidu SS, Patel P.
    Int J Cardiol; 2016 Jan 01; 202():469-76. PubMed ID: 26436676
    [Abstract] [Full Text] [Related]

  • 7. Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes.
    Schoos MM, Mehran R, Dangas GD, Yu J, Baber U, Clemmensen P, Feit F, Gersh BJ, Guagliumi G, Ohman EM, Pocock SJ, Witzenbichler B, Stone GW.
    Am J Cardiol; 2016 Dec 01; 118(11):1661-1668. PubMed ID: 27836132
    [Abstract] [Full Text] [Related]

  • 8. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM, EARLY ACS Investigators.
    JACC Cardiovasc Interv; 2012 Sep 01; 5(9):927-35. PubMed ID: 22995880
    [Abstract] [Full Text] [Related]

  • 9. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ, Sandhu P, Mehran R, McEntegart M, Cristea E, Brener SJ, Xu K, Fahy M, Généreux P, Wessler JD, Stone GW.
    Am J Cardiol; 2014 Jan 01; 113(1):36-43. PubMed ID: 24169019
    [Abstract] [Full Text] [Related]

  • 10. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score.
    Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Della Riva D, Fahy M, Xu K, Stone GW.
    JACC Cardiovasc Interv; 2012 Nov 01; 5(11):1108-16. PubMed ID: 23174634
    [Abstract] [Full Text] [Related]

  • 11. Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial.
    Généreux P, Bernard S, Palmerini T, Caixeta A, Rosner G, Reiss GR, Xu K, Mehran R, Stone GW, ACUITY Trial Investigators.
    EuroIntervention; 2015 Aug 01; 11(4):399-406. PubMed ID: 25022226
    [Abstract] [Full Text] [Related]

  • 12. Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Yudi MB, Eccleston D, Andrianopoulos N, Farouque O, Duffy SJ, Brennan A, Reid C, Clark DJ, Ajani AE, Melbourne Interventional Group.
    Intern Med J; 2015 Oct 01; 45(10):1032-7. PubMed ID: 26013065
    [Abstract] [Full Text] [Related]

  • 13. Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
    Molife C, Frech-Tamas F, DeKoven M, Effron MB, Karkare S, Zhu Y, Larmore C, Lu J, McCollam P, Marrett E, Vetrovec GW.
    J Med Econ; 2015 Oct 01; 18(11):898-908. PubMed ID: 26086414
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events.
    Zgheib AZ, Jdaidani J, Akl E, Khalil S, Chaabo O, Piazza N, Sawaya FJ, Rebeiz AG.
    Int J Clin Pract; 2024 Oct 01; 2024():6219301. PubMed ID: 38390376
    [Abstract] [Full Text] [Related]

  • 15. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Brener SJ, Cristea E, Kirtane AJ, McEntegart MB, Xu K, Mehran R, Stone GW.
    JACC Cardiovasc Interv; 2013 Jan 01; 6(1):36-43. PubMed ID: 23266233
    [Abstract] [Full Text] [Related]

  • 16. Prevalence, correlation and clinical outcome of intra-procedural stent thrombosis in patients undergoing primary percutaneous coronary intervention for acute coronary syndrome.
    Xu Y, Qu X, Fang W, Chen H.
    J Interv Cardiol; 2013 Jun 01; 26(3):215-20. PubMed ID: 23551235
    [Abstract] [Full Text] [Related]

  • 17. The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial.
    Madhavan MV, Généreux P, Palmerini T, Caixeta A, Xu K, McAndrew TC, Francese DP, Kirtane AJ, Mehran R, Stone GW.
    J Invasive Cardiol; 2015 Apr 01; 27(4):203-11. PubMed ID: 25840404
    [Abstract] [Full Text] [Related]

  • 18. [Changes of monocyte and monocyte-platelet aggregates in different subgroups of thrombotic events in patients with acute myocardial infarction during PCI].
    Wang S, Sun C, Liao W, Wu Z, Wang Y, Huang X, Lu S, Dong X, Shuai F, Li B.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul 01; 33(7):959-965. PubMed ID: 28712405
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.